Completed PHASE4 INTERVENTIONAL 2-arm NCT02447536

Trial of Two Strains of BCG (BCGSTRAIN)

Evaluating the Effect of Different BCG Strains on Early Life Hospital Admissions in Guinea-Bissau: A Randomised Trial

Sponsor: Bandim Health Project

Conditions Bacille Calmette-Guérin Morbidity

Interventions BCG-Denmark 1331 (Statens Serum Institute) BCG-Russia-I (Serum Institute of India)

Updated 7 times since 2017 Last updated: Dec 13, 2020 Started: Dec 8, 2014 Primary completion: Nov 24, 2017 Completion: May 1, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Bacille Calmette-Guérin and Morbidity, this trial is completed. The trial is conducted by Bandim Health Project and has accumulated 7 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jul 2018 — Jan 2021 [monthly]

Completed PHASE4

Status: Active Not Recruiting → Completed
Jun 2018 — Jul 2018 [monthly]

Active Not Recruiting PHASE4

▶ Show 2 earlier versions

Jan 2018 — Jun 2018 [monthly]

Active Not Recruiting PHASE4

Status: Recruiting → Active Not Recruiting
Jan 2017 — Jan 2018 [monthly]

Recruiting PHASE4

First recorded

Dec 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bandim Health Project
Statens Serum Institut

Data source: Bandim Health Project

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bissau, Guinea-Bissau